Cargando…
The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes
Type 1 diabetes (T1D) remains a major health problem worldwide, with a steadily rising incidence yet no cure. Phosphoinositide 3-kinase-γ (PI3Kγ), a member of a family of lipid kinases expressed primarily in leukocytes, has been the subject of substantial research for its role in inflammatory diseas...
Autores principales: | Azzi, Jamil, Moore, Robert F., Elyaman, Wassim, Mounayar, Marwan, El Haddad, Najib, Yang, Sunmi, Jurewicz, Mollie, Takakura, Ayumi, Petrelli, Alessandra, Fiorina, Paolo, Ruckle, Thomas, Abdi, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357271/ https://www.ncbi.nlm.nih.gov/pubmed/22403300 http://dx.doi.org/10.2337/db11-0134 |
Ejemplares similares
-
Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes
por: Jurewicz, Mollie, et al.
Publicado: (2010) -
Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes
por: Fiorina, Paolo, et al.
Publicado: (2008) -
A Novel Clinically Relevant Strategy to Abrogate Autoimmunity and Regulate Alloimmunity in NOD Mice
por: Vergani, Andrea, et al.
Publicado: (2010) -
Phosphoinositide 3-kinase inhibitor AS605240 ameliorates streptozotocin-induced Alzheimer’s disease like sporadic dementia in experimental rats
por: Alluri, Ramesh, et al.
Publicado: (2020) -
AS-605240 Blunts Osteoporosis by Inhibition of Bone Resorption
por: Sun, Jiacheng, et al.
Publicado: (2023)